·Ö×ÓÉúÎïѧÔÚÒ½Ò©ÖеÄÑо¿½øÕ¹¼°Ó¦Óà ÏÂÔØ±¾ÎÄ

²Î¿¼ÎÄÏ×

1. 2. 3. 4. 5. 6.

7. 8.

Garland E.Allen. ÎâÏþ½­.·Ö×ÓÉúÎïѧµÄÆðÔ´ºÍ·¢Õ¹Ê·¡£2009

ÕŻ۲©¡£·Ö×ÓÉúÎï¼¼ÊõÔÚÏÖ´úҽѧÖеÄÓ¦ÓÃ.China High Technology Enterprises.2007 Çñ ·¼£¬·ü½¡Ãñ£¬½ðµÂÃô¡£ÒÅ´«¶àÑùÐԵķÖ×Ó¼ì²â£ÛJ£Ý.ÉúÎï¶àÑùÐÔ,1998,6(2),143 ФСºÓ£¬ºØ³Ðɽ£¬ÏÄÎľ꣬µÈ 21ÊÀ¼ÍÎÒ¹úÉúҩѧÑо¿µÄ»úÓöÓëÌôÕ½£ÛJ£Ý.ÖйúҩѧÔÓÖ¾,1999£¬34£¨7£©£º348

Varela MC,Arce A,Greiner B. Cyclosporine A-induced decrease in callbindin-D28 kD in rat kidney but not in cerebral corex and cerebellum. Biochem Parmacol,1998,55(12);2043-6

Fountoulakis M, Berndt P, Bolesterli UA.Two-dimensional database of mouse liver proteins£ºchanges in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis,2000,1(11):2148-61.

Ruepp SU, TongeRP,Shaw J.genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci,2002,65(1):135-50

Man WJ, WhiteIR, Bryant. Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat. Proteomics,2002,2(11):1577-85